New Liposarcomas Study Findings Have Been Reported from AntiCancer Inc. (Targeting Autophagy With the Synergistic Combination of Chloroquine and Rapamycin As a Novel Effective Treatment for Well-differentiated Liposarcoma).

Keywords: San Diego; State:California; United States; North and Central America; Amebicides; Antibiotics; Antiinfectives; Antimalarial Agents; Antirheumatics; Apoptosis; Business; Cancer; Cellular Physiology; Chloroquine Therapy; Drugs and Therapies; Health and Medicine; Liposarcomas; Oncology; Pharmaceuticals; Rapamycin Therapy EN San Diego State:California United States North and Central America Amebicides Antibiotics Antiinfectives Antimalarial Agents Antirheumatics Apoptosis Business Cancer Cellular Physiology Chloroquine Therapy Drugs and Therapies Health and Medicine Liposarcomas Oncology Pharmaceuticals Rapamycin Therapy 626 626 1 08/14/23 20230815 NES 230815 2023 AUG 15 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators discuss new findings in Oncology - Liposarcomas. The news reporters obtained a quote from the research from AntiCancer Inc., "Chloroquine (CQ), an antimalarial drug, can inhibit autophagy and induce apoptosis in cancer cells. [Extracted from the article]